Endocrinology Research and Practice
Review Article

Cell-free DNA as a Clinical Indicator in Maternal Blood

1.

University of Baghdad, College of Medicine, Department of Physiology, Baghdad, Iraq

2.

Al-Nisour University College, Department of Anesthesia Techniques, Baghdad, Iraq

Endocrinol Res Pract 2019; 23: 174-180
DOI: 10.25179/tjem.2019-65572
Read: 2040 Downloads: 392 Published: 01 September 2019

ABSTRACT

As many expensive and invasive procedures are used for the diagnosis or follow-up of clinical conditions, the measurement of cell-free DNA is a promising, noninvasive method, which considers using blood, follicular fluid, or seminal fluid. This method is used to determine chromosomal abnormalities, genetic disorders, and indicators of some diseases such as polycystic ovary syndrome, pre-eclampsia, and some malignancies. Cell-free DNA, which are DNA fragments outside the nucleus, originates from an apoptotic process. However, to be used as a marker for the previously mentioned diseases is still under investigation. We discuss some aspects of using cell-free DNA measurements as an indicator or marker for pathological conditions.

 

Files
EISSN 2822-6135